{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:13Z","timestamp":1792788253538,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Pujiang Program","award":["22PJD065"],"award-info":[{"award-number":["22PJD065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Induced neural stem cells (iNSCs), which have similar properties to neural stem cells and are able to self-proliferate and differentiate into neural cell lineages, are expected to be potential cells for the treatment of neurodegeneration disease. However, cell therapy based on iNSCs transplantation is limited by the inability to acquire sufficient quantities of iNSCs.  Previous studies have found that mouse and human fibroblasts can be directly reprogrammed into iNSCs with a single factor, Sox2. Here, we induced mouse embryonic fibroblasts (MEFs) into iNSCs by combining valproic acid (VPA) with the induction factor Sox2, and the results showed that VPA significantly improved the conversion efficiency of fibroblasts to iNSCs. The iNSCs exhibited typical neurosphere-like structures that can express NSCs markers, such as Sox2, Nestin, Sox1, and Zbtb16, and could differentiate into neurons, astrocytes, and oligodendrocytes in vitro. Subsequently, the iNSCs were stereotactically transplanted into the hippocampus of APP\/PS1 double transgenic mice (AD mice). Post-transplantation, the iNSCs showed long-term survival, migrated over long distances, and differentiated into multiple types of functional neurons and glial cells in vivo. Importantly, the cognitive abilities of APP\/PS1 mice transplanted with iNSCs exhibited significant functional recovery. These findings suggest that VPA enhances the conversion efficiency of fibroblasts into iNSCs when used in combination with Sox2, and iNSCs hold promise as a potential donor material for transplantation therapy in Alzheimer\u2019s disease.<\/jats:p>","DOI":"10.1186\/s40659-024-00568-0","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T09:44:55Z","timestamp":1732441495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Study on the therapeutic potential of induced neural stem cells for Alzheimer's disease in mice"],"prefix":"10.1186","volume":"57","author":[{"given":"Qiongqiong","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3083-3025","authenticated-orcid":false,"given":"Imran Ibrahim","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"key":"568_CR1","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1002\/alz.14049","volume":"20","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xiao X, Yang Y, Yao R, Yang Q, Zhu Y, et al. The risk of Alzheimer\u2019s disease and cognitive impairment characteristics in eight mental disorders: a UK Biobank observational study and Mendelian randomization analysis. Alzheimers Dement. 2024;20:4841\u201353.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"568_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209499","volume":"103","author":"CA Hamilton","year":"2024","unstructured":"Hamilton CA, Donaghy PC, Durcan R, Ciafone J, Olsen K, Roberts G, et al. Outcomes of patients with mild cognitive impairment with Lewy bodies or Alzheimer disease at 3 and 5 years after diagnosis. Neurology. 2024;103(2): e209499.","journal-title":"Neurology"},{"key":"568_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.937133","volume":"15","author":"P Goel","year":"2022","unstructured":"Goel P, Chakrabarti S, Goel K, Bhutani K, Chopra T, Bali S. Neuronal cell death mechanisms in Alzheimer\u2019s disease: an insight. Front Mol Neurosci. 2022;15: 937133.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"568_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13287-017-0567-5","volume":"8","author":"T Duncan","year":"2017","unstructured":"Duncan T, Valenzuela M. Alzheimer\u2019s disease, dementia, and stem cell therapy. Stem Cell Res Ther. 2017;8(1):111.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"568_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-017-2738-1","volume":"371","author":"X Zhao","year":"2018","unstructured":"Zhao X, Moore DL. Neural stem cells: developmental mechanisms and disease modeling. Cell Tissue Res. 2018;371(1):1\u20136.","journal-title":"Cell Tissue Res"},{"key":"568_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuint.2017.02.006","volume":"106","author":"SE Marsh","year":"2017","unstructured":"Marsh SE, Blurton-Jones M. Neural stem cell therapy for neurodegenerative disorders: the role of neurotrophic support. Neurochem Int. 2017;106:94\u2013100.","journal-title":"Neurochem Int"},{"issue":"3","key":"568_CR7","first-page":"1172","volume":"21","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Zhang N, Hu N, Jiang R, Lu H, Xuan A, et al. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein\/presenilin 1 transgenic mouse model of Alzheimer\u2019s disease. Mol Med Rep. 2020;21(3):1172\u201380.","journal-title":"Mol Med Rep"},{"issue":"1","key":"568_CR8","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-018-33017-6","volume":"8","author":"LM McGinley","year":"2018","unstructured":"McGinley LM, Kashlan ON, Bruno ES, Chen KS, Hayes JM, Kashlan SR, et al. Human neural stem cell transplantation improves cognition in a murine model of Alzheimer\u2019s disease. Sci Rep. 2018;8(1):14776.","journal-title":"Sci Rep"},{"key":"568_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12967-014-0371-2","volume":"13","author":"L Mazzini","year":"2015","unstructured":"Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015;13:17.","journal-title":"J Transl Med"},{"issue":"3","key":"568_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1242\/bio.016402","volume":"5","author":"S Paul","year":"2016","unstructured":"Paul S, Pflieger L, Dansithong W, Figueroa KP, Gao F, Coppola G, et al. Co-expression networks in generation of induced pluripotent stem cells. Biol Open. 2016;5(3):300\u201310.","journal-title":"Biol Open"},{"issue":"6","key":"568_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/cyto.a.21072","volume":"79","author":"U Tiemann","year":"2011","unstructured":"Tiemann U, Sgodda M, Warlich E, Ballmaier M, Scholer HR, Schambach A, et al. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells. Cytometry A. 2011;79(6):426\u201335.","journal-title":"Cytometry A"},{"issue":"5","key":"568_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"issue":"7359","key":"568_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang ZP, Yang N, Vierbuchen T, Ostermeier A, Fuentes DR, Yang TQ, et al. Induction of human neuronal cells by defined transcription factors. Nature. 2011;476(7359):220\u20133.","journal-title":"Nature"},{"issue":"7359","key":"568_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature10323","volume":"476","author":"AS Yoo","year":"2011","unstructured":"Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, Li Y, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011;476(7359):228\u201331.","journal-title":"Nature"},{"issue":"1","key":"568_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s42003-023-04627-2","volume":"6","author":"M Fontcuberta-PiSunyer","year":"2023","unstructured":"Fontcuberta-PiSunyer M, Garcia-Alaman A, Prades E, Tellez N, Alves-Figueiredo H, Ramos-Rodriguez M, et al. Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors. Commun Biol. 2023;6(1):256.","journal-title":"Commun Biol"},{"issue":"3","key":"568_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/mp.15500","volume":"49","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, Xu X, Chen B, Liao Y, Guan X, He Y, et al. Ultrasound-targeted microbubbles destruction assists dual delivery of beta-amyloid antibody and neural stem cells to restore neural function in transgenic mice of Alzheimer\u2019s disease. Med Phys. 2022;49(3):1357\u201367.","journal-title":"Med Phys"},{"issue":"1","key":"568_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12929-020-0622-x","volume":"27","author":"Y Hayashi","year":"2020","unstructured":"Hayashi Y, Lin HT, Lee CC, Tsai KJ. Effects of neural stem cell transplantation in Alzheimer\u2019s disease models. J Biomed Sci. 2020;27(1):29.","journal-title":"J Biomed Sci"},{"issue":"9","key":"568_CR18","doi-asserted-by":"publisher","first-page":"7739","DOI":"10.3390\/ijms24097739","volume":"24","author":"Q Cheng","year":"2023","unstructured":"Cheng Q, Ma X, Liu J, Feng X, Liu Y, Wang Y, et al. Pharmacological inhibition of the asparaginyl endopeptidase (AEP) in an Alzheimer\u2019s disease model improves the survival and efficacy of transplanted neural stem cells. Int J Mol Sci. 2023;24(9):7739.","journal-title":"Int J Mol Sci"},{"key":"568_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113112","volume":"324","author":"AC Boese","year":"2020","unstructured":"Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in Alzheimer\u2019s disease. Exp Neurol. 2020;324: 113112.","journal-title":"Exp Neurol"},{"issue":"10","key":"568_CR20","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","volume":"274","author":"D Moechars","year":"1999","unstructured":"Moechars D, Dewachter I, Lorent K, Revers\u00e9 D, Baekelandt V, Naidu A, et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem. 1999;274(10):6483\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"568_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11(1):47\u201360.","journal-title":"J Neurosci Methods"},{"key":"568_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ymeth.2017.09.007","volume":"133","author":"E Shahbazi","year":"2018","unstructured":"Shahbazi E, Mirakhori F, Ezzatizadeh V, Baharvand H. Reprogramming of somatic cells to induced neural stem cells. Methods. 2018;133:21\u20138.","journal-title":"Methods"},{"issue":"27","key":"568_CR23","doi-asserted-by":"publisher","first-page":"14199","DOI":"10.1074\/jbc.M115.713578","volume":"291","author":"SM Kim","year":"2016","unstructured":"Kim SM, Kim JW, Kwak TH, Park SW, Kim KP, Park H, et al. Generation of integration-free induced neural stem cells from mouse fibroblasts. J Biol Chem. 2016;291(27):14199\u2013212.","journal-title":"J Biol Chem"},{"issue":"7","key":"568_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/cr.2012.73","volume":"22","author":"GH Liu","year":"2012","unstructured":"Liu GH, Yi F, Suzuki K, Qu J, Izpisua Belmonte JC. Induced neural stem cells: a new tool for studying neural development and neurological disorders. Cell Res. 2012;22(7):1087\u201391.","journal-title":"Cell Res"},{"issue":"s1","key":"568_CR25","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.3233\/JAD-220721","volume":"94","author":"X Chen","year":"2023","unstructured":"Chen X, Jiang S, Wang R, Bao X, Li Y. Neural stem cells in the treatment of Alzheimer\u2019s disease: current status, challenges, and future prospects. J Alzheimers Dis. 2023;94(s1):S173\u201386.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"568_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"J Piao","year":"2021","unstructured":"Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, et al. Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell. 2021;28(2):217\u201329.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"568_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"3","key":"568_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/brainsci13030524","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, Huang L, Yang Y, Xu W, Qin Q, Qin R, et al. Somatic cell reprogramming for nervous system diseases: techniques, mechanisms, potential applications, and challenges. Brain Sci. 2023;13(3):524.","journal-title":"Brain Sci"},{"issue":"1","key":"568_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41420-023-01532-9","volume":"9","author":"L Nie","year":"2023","unstructured":"Nie L, Yao D, Chen S, Wang J, Pan C, Wu D, et al. Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke. Cell Death Discov. 2023;9(1):215.","journal-title":"Cell Death Discov"},{"issue":"1","key":"568_CR30","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1038\/s41467-018-05209-1","volume":"9","author":"D Xiao","year":"2018","unstructured":"Xiao D, Liu X, Zhang M, Zou M, Deng Q, Sun D, et al. Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a. Nat Commun. 2018;9(1):2865.","journal-title":"Nat Commun"},{"issue":"1","key":"568_CR31","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1038\/s41467-021-27055-4","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu Z, Zhou J, Ramadurai DKA, Mortenson KL, Aguilera-Jimenez E, et al. A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nat Commun. 2021;12(1):7139.","journal-title":"Nat Commun"},{"issue":"1","key":"568_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-020-00242-3","volume":"5","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xiong X, Sun Y. Functional characterization of SOX2 as an anticancer target. Signal Transduct Target Ther. 2020;5(1):135.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"568_CR33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4103\/1673-5374.293138","volume":"16","author":"B Polis","year":"2021","unstructured":"Polis B, Samson AO. Neurogenesis versus neurodegeneration: the broken balance in Alzheimer\u2019s disease. Neural Regen Res. 2021;16(3):496\u20137.","journal-title":"Neural Regen Res"},{"issue":"2","key":"568_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2023.01.002","volume":"30","author":"E Salta","year":"2023","unstructured":"Salta E, Lazarov O, Fitzsimons CP, Tanzi R, Lucassen PJ, Choi SH. Adult hippocampal neurogenesis in Alzheimer\u2019s disease: a roadmap to clinical relevance. Cell Stem Cell. 2023;30(2):120\u201336.","journal-title":"Cell Stem Cell"},{"key":"568_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116974","volume":"416","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Kabir MT, Tewari D, Mamun AA, Mathew B, Aleya L, et al. Revisiting the role of brain and peripheral Abeta in the pathogenesis of Alzheimer\u2019s disease. J Neurol Sci. 2020;416: 116974.","journal-title":"J Neurol Sci"},{"issue":"1","key":"568_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid beta-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8(1):248.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"568_CR37","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The amyloid-beta pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5481\u2013503.","journal-title":"Mol Psychiatry"},{"key":"568_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","volume":"139","author":"J Griffiths","year":"2023","unstructured":"Griffiths J, Grant SGN. Synapse pathology in Alzheimer\u2019s disease. Semin Cell Dev Biol. 2023;139:13\u201323.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"568_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13195-022-01150-0","volume":"14","author":"KH Shim","year":"2022","unstructured":"Shim KH, Kang MJ, Youn YC, An SSA, Kim S. Alpha-synuclein: a pathological factor with Abeta and tau and biomarker in Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):201.","journal-title":"Alzheimers Res Ther"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-024-00568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-024-00568-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-024-00568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T10:02:02Z","timestamp":1732442522000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-024-00568-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1186\/s40659-024-00568-0","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,24]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were conducted in accordance with the Shanghai Ethics Committee, and all procedures followed the guidelines of the Chinese Animal Welfare Agency.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}